TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2017 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2017 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.
Foreign entity interest: Teva Pharmaceutical Industries Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| DEBRA BARRETT | — |
| SHANNON DZUBIN | — |
| GRANT ERDEL | — |
| ROBERT FALB | — |
Trade (domestic/foreign) TRD
Trans-Pacific Partnership Trade Agreement; Trans-Atlantic Trade & Investment Partnership Agreement.
Foreign entity interest: Teva Pharmaceutical Industries Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBRA BARRETT | — |
| SHANNON DZUBIN | — |
| GRANT ERDEL | — |
Copyright/Patent/Trademark CPT
Patent reform proposals.
Foreign entity interest: Teva Pharmaceutical Industries Ltd., as the indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| DEBRA BARRETT | — |
| SHANNON DZUBIN | — |
| GRANT ERDEL | — |
| ROBERT FALB | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.